Krónikus mieloid leukémia (CML): vizsgálatok itt: Hongkong

2 trials · From ClinicalTrials.gov, checked 2026. november 14.. Ask the study team whether a trial fits you.

• 2. fázisNot yet taking people in Hongkong
  Asciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo-HSCT) of Patient With Ph+ B-ALL or Blastic Transformed CML

  Where

  Hong Kong

  Életkor

  18 év and over

  People

  45

  Run by

  The University of Hong Kong

  See details and how to joinNCT07493408
• 2. fázisTaking people
  Oral-ATO for TP53-mutated Myeloid Malignancies

  Where

  Hong Kong

  Életkor

  18 év and over

  People

  30

  Run by

  The University of Hong Kong

  See details and how to joinNCT06778187